Bmper Inhibits Endothelial Expression of Inflammatory Adhesion Molecules and Protects Against Atherosclerosis by Pi, X. et al.
Bmper Inhibits Endothelial Expression of Inflammatory
Adhesion Molecules and Protects Against Atherosclerosis
Xinchun Pi1,2,*, Pamela Lockyer1,2,*, Laura A. Dyer1,2, Jonathan C. Schisler1,2, Brooke
Russell1,2, Stephen Carey1,2, Daniel Timothy Sweet1,3, Zhongming Chen1,3, Ellie Tzima1,3,
Monte S. Willis1,4, Jonathon W. Homeister1,4, Martin Moser5, and Cam Patterson1,2
1UNC McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599, USA
2Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
3Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC
27599, USA
4Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC
27599, USA
5Department Medicine III, University of Freiburg, Freiburg, Germany
Abstract
Objective—Bone morphogenetic proteins (Bmps) are important mediators of inflammation and
atherosclerosis, though their mechanism of action is not fully understood. To better understand the
contribution of the Bmp signaling pathway plays in vascular inflammation, we investigated the
role of Bmper (Bmp-endothelial cell precursor-derived regulator), an extracellular Bmp
modulator, in an induced in vivo model of inflammation and atherosclerosis.
Methods and Results—We crossed apolipoprotein E-deficient (ApoE−/−) mice with mice
missing one allele of Bmper (Bmper+/−, used in place of Bmper−/− mice that die at birth) and
measured the development of atherosclerosis in mice fed a high fat diet. Bmper haploinsufficiency
in ApoE−/− mice (Bmper+/−;ApoE−/− mice) led to a more severe phenotype compared to
Bmper+/+;ApoE−/− mice. Bmper+/−;ApoE−/− mice also exhibited increased Bmp activity in
endothelial cells in both the greater and lesser curvatures of the aortic arch, suggesting a role for
Bmper in regulating Bmp-mediated inflammation associated with laminar and oscillatory shear
stress. siRNA knockdown of Bmper in human umbilical vein endothelial cells caused a dramatic
increase in the inflammatory markers ICAM1 and VCAM1 at rest and following exposure to
oscillatory and laminar shear stress.
Conclusion—We conclude that Bmper is a critical regulator of Bmp-mediated vascular
inflammation and that the fine-tuning of Bmp and Bmper levels is essential in the maintenance of
normal vascular homeostasis.
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Atherosclerosis is a disease that results from plaque formation within arteries, resulting in
arterial hardening and narrowing. It is mediated by a chronic inflammatory process
characterized by the accumulation of lipids and inflammatory cells (plaques) along the inner
walls of arteries1. Although plaque formation is a complex process, endothelial
inflammation has been identified as one of the critical initiating factors1. Endothelial
inflammation can be induced by decreases or disruptions in blood flow, making some
regions of the vasculature more prone to plaque formation2, 3. For example, arterial regions
that are exposed to uniform, unidirectional blood flow with high shear stress are protected
from endothelial inflammation and have a lower incidence of atherosclerotic plaque
formation3, 4. In comparison, atherosclerotic lesions develop predominantly at branches,
bends and bifurcations in arteries5-7, where endothelial cells are exposed to low or disturbed
fluid shear stress, resulting in low mean and oscillatory shear stress on the endothelial cells.
In these lesion-prone regions, disturbed or oscillatory shear stress increases expression of
bone morphogenetic proteins (Bmps) and their antagonists in the vascular endothelium8, 9.
In turn, Bmps activate an inflammatory response characterized by the expression of
adhesion molecules, like intracellular adhesion molecule 1 (ICAM1) and vascular cell
adhesion molecule 1 (VCAM1) on the endothelial surface9. Despite this, animal studies
examining the direct role of Bmp on vascular inflammation have been inconclusive, with
some studies reporting a decrease in inflammatory responses and atherosclerotic lesion
formation when Bmp activity is increased10, whereas others concluding that Bmp plays a
pro-inflammatory role10, 11. Although each of these studies support a central role for Bmp-
mediated endothelial inflammation in atherosclerosis, some uncertainty remains about the
precise contribution of Bmp signaling to endothelial inflammation and atherosclerosis.
Bmps belong to the transforming growth factor (TGF-β) superfamily and play important
roles in cellular processes such as bone formation, proliferation, differentiation, motility,
vasculogenesis and angiogenesis (reviewed by Moreno-Miralles12). More specifically,
Bmp4, together with Bmp2 and Bmp6, demonstrate important roles in endothelial
differentiation, migration and angiogenesis13-16. Previously, we identified a novel
extracellular modulator of Bmp, Bmp-endothelial cell precursor derived regulator (Bmper;
also called crossveinless 2 in Drosophila melanogaster), which is required for hematopoietic
and vascular development and hypoxia-induced retinal neovascularization13, 14, 17. We have
also demonstrated that Bmper regulates Bmp4 activity in a dose-dependent manner13.
Recent reports show that Bmper is induced by inflammatory-regulatory stimuli such as
oscillatory shear stress and mevastatin, and inhibits tumor necrosis factor-α (TNFα)-
induced endothelial inflammation18, 19, suggesting that Bmper acts in an anti-inflammatory
capacity in endothelial cells by inhibiting Bmp activity. This led us to question whether
Bmper may also inhibit the endothelial inflammation and subsequent pathology associated
with atherosclerosis.
In this study, we used the apolipoprotein E (ApoE)−/− mouse atherosclerotic model to study
the effects of Bmper haploinsufficiency on the development of atherosclerosis. We used
Bmper+/− mice instead of Bmper−/− mice because Bmper−/− mice die at birth13.
Bmper+/−;ApoE−/− mice fed a high fat diet displayed an exacerbated inflammatory vascular
response compared to ApoE−/− mice with the wild-type Bmper gene (Bmper+/+;ApoE−/−).
Mechanistically, we demonstrate that the protective effects afforded by Bmper are
dependent on the inhibition of Bmp activity. These data demonstrate for the first time that
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Bmper is a novel player in the development of atherosclerosis and in fluid shear stress-
modulated inflammatory responses in endothelial cells. Taken together, it suggests that




Bmper+/− mice, previously generated in our laboratory on a C57BL/6J genetic
background13, were crossed with ApoE−/− mice to generate Bmper+/−;ApoE−/− mice. We
used the Bmper+/− mice instead of Bmper−/− mice because Bmper−/− mice die at birth13. All
adult mice were fed with the standard chow or a high-fat/high-cholesterol diet (Western diet)
(Harlan Laboratories, Indianapolis, IN) for 20 weeks. Body weight of mice was monitored
before and after they were fed with different diets. Blood serum was obtained every four
weeks. All animal experimental procedures were performed according to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the
Institutional Committee for the Use of Animals in Research.
Lipid analysis
Mice were fasted for 18 hours before blood sampling. Less than 200 μl of blood was
collected through sub-mandibular bleeding using a lancet. The total cholesterol level was
measured enzymatically with a commercially available kit (Infinity kits, Thermo Scientific,
Waltham, MA).
Lesion quantification
The mice were euthanized and perfusion fixed with 10% buffered formalin via the left
ventricle for 5 minutes. The lesions located in the aorta and aortic sinuses were analyzed
using Oil Red O staining. To measure lesions in the aorta, the whole aorta, including the
ascending arch, thoracic and abdominal segments, was dissected, gently cleaned of
adventitial tissue and stained with Oil Red O. The surface lesion area was quantified with
ImageJ software and is presented as a percentage of the total surface area of the whole aorta.
To measure the lesions in the aortic sinuses, the heart and proximal aorta were excised, and
the apex and lower half of the ventricles were removed. The remaining sample was
embedded in OCT (Tissue-Tek, Fisher Scientific, Pittsburgh, PA) and frozen on dry ice.
Starting from the appearance of the aortic valve, serial frozen sections at 5-μm thickness
were collected until the aortic valves were completely sectioned following the previously
described protocol20. Sections were stained with eosin and Oil Red O. The slides were
imaged by light microscopy, and the atherosclerotic lesion area located in aortic sinus area
was quantified with ImageJ and averaged over a 280 μm region.
Calcification quantification
Deposited calcium in the aorta was detected by staining with von Kossa. The 5-μm
cryosections of aortic sinus were prepared as described above and subjected to the von
Kossa staining procedure. The calcification area from each section was quantified as a
percentage of the total vessel cross-sectional area using ImageJ software.
ELISA measurements
Blood samples were drawn from mice after consuming the high fat diet or standard chow for
4 weeks. Soluble VCAM (sVCAM) and soluble ICAM (sICAM) were measured in plasma
in triplicate using an enzyme-linked immunosorbent assay (ELISA) method (R&D Systems,
Minneapolis, MN).
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Recombinant human Bmp4 and Bmper protein and antibodies recognizing Bmper and Bmp4
were obtained from R&D Systems. VCAM1 antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA) for Western blotting and Chemicon for
immunofluorescence (Millipore, Billerica, MA). The ICAM1 antibody was purchased from
Cell Signaling Technology (Danvers, MA) and used for western blotting experiments. An
additional ICAM1 antibody (purchased from Chemicon) was used for immunofluorescence
experiments. The pSmad1,5,8 antibody was purchased from Cell Signaling Technology and
used for both western blotting and immunofluorescence experiments.
Cell culture and siRNA transfection
HUVECs (human umbilical vein endothelial cells) were purchased from Lonza and cultured
in endothelial basal medium (EBM; Lonza, Allendale, NJ) supplemented with
hydrocortisone, bovine brain extract, epidermal growth factor and 2% fetal calf serum. The
cells from passages 4-8 were used for experiments. The stealth siRNA duplexes were
obtained from Invitrogen (Grand Island, NY). The siRNAs against mouse Bmper are a
mixture of the duplexes of 5′-gaauuucagccagaaggaagcaaau-3′ and 5′-
ggagagaugugguccucuaucaauu-3′. The siRNA against mouse Bmp4 is a duplex of 5′-
GCAUGUCAGGAUUAGCCGAUCGUUA-3′. The control siRNA is the Stealth™ RNAi
negative control duplex (Cat. No. 12935-300) and was purchased from Invitrogen. The
siRNAs were transfected into HUVECs according to the manufacturer's recommended
protocol for Nucleofection (Amaxa; the HUVEC protocol). Briefly, for each sample, 2×105
HUVECs were transfected with 300 pmol siRNA. The experiments with Bmp4 or Bmper
siRNA-transfected HUVECs were performed one day or four days later, respectively. The
siRNAs resulted in more than 70% knockdown of the protein levels of Bmp4 and Bmper.
Shear stress assays
HUVECs were post-confluent for 48 hours before the performance of fluid shear stress
experiment to decrease the background signals. Laminar shear stress assay was described
previously21. Briefly, confluent cells in 10-cm dish were exposed to shear stress using the
cone and plate flow chamber system for eight hours at 20 dyne cm-2 for laminar shear stress
or ±5 dyn cm-2 for oscillatory shear stress experiments.
Immunoblotting
Cells were harvested in lysis buffer (1% Triton X-100, 50 mmol/L Tris (pH 7.4), 150 mmol/
L NaCl, 1 mmol/L Na3VO4 and 0.1% protease inhibitor mixture; Sigma) and clarified by
centrifugation at 16,000 g. Proteins were separated by SDS-PAGE and transferred to
nitrocellulose membranes.
Immunofluorescence
The aortic arch segments were dissected out and gently cleaned of the adventitia. The aortic
fragments located at the greater curvature (GC) and lesser curvature (LC) were separated
and fixed in 3.7% formaldehyde for 10 minutes at room temperature. The aortic fragments
were sequentially treated with 70% ethanol for 30 minutes and 5% hydrogen peroxide in
methanol. Then, the segments were washed with water for 5 minutes. For the phospho-Smad
1, 5, 8 antibody, the samples were soaked in boiling citric acid buffer (10 mmol/L, pH 6.0)
for 9 minutes to expose the antigens. Next, the aortic fragments or 5-μm cryosections of the
aortic root were blocked with 5% heat-inactivated goat serum for 1 hour and then incubated
overnight with primary antibodies against ICAM1, VCAM1, CD31 or CD68 diluted in the
blocking solution. After three washes in TBS, cells were incubated in the dark with a second
antibody conjugated with Alexa Fluor 488 or 568 (Molecular Probes, Eugene, OR) in
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blocking solution for 90 minutes at 37 °C. After 3 washes in TBS, the fragments were
counterstained with DAPI for phospho-Smad1, 5 and 8 staining. The en face images of the
endothelial layer and the cross-sectional images of the aortic root were visualized by
confocal laser scanning microscopy.
Statistical analysis
Data are shown as the mean ± SE for 3 to 4 separate experiments. Differences were analyzed
with two-way ANOVA and post-hoc analyses such as Student's t-test when needed. Values
of P≤0.05 were considered statistically significant.
Results
Bmper expression protects against atherosclerotic lesion formation and calcification
Accumulated evidence suggests that Bmper protects endothelial cells from inflammation by
inhibiting Bmp activity18, 19. Therefore, we used the ApoE−/− mouse model, in which a high
fat diet leads to accelerated atherosclerotic lesion formation and arterial calcification, to
analyze the in vivo effect of reduced Bmper expression on vascular inflammation. We
crossed wild-type or ApoE−/− mice with mice that had either one or two functional Bmper
alleles, resulting in four genotypes of experimental mice: Bmper+/+;ApoE+/+,
Bmper+/−;ApoE+/+, Bmper+/+;ApoE−/−, Bmper+/−;ApoE−/−. These mice were then fed either
a standard chow (CH) or high fat (HF) diet for twenty weeks and the formation of
atherosclerotic plaques in the aorta and aortic sinus regions was evaluated by Oil Red O
staining. ApoE−/− mice that were haploinsufficient for Bmper expression
(Bmper+/−;ApoE−/−) responded to the high fat diet with enhanced plaque formation
compared to Bmper+/+;ApoE−/− mice (28.35±2.23% vs. 17.96±3.00%, P=0.016), as
measured by en face staining of aortic lesions (including both thoracic and abdominal aorta,
Figures 1A, 1B). In addition, cross-sectional analysis of aortic sinus lesions revealed that the
plaques formed in the Bmper+/−;ApoE−/− mice were larger compared to lesions in
Bmper+/+;ApoE−/− mice (0.38±0.02% vs. 0.29±0.03%, P=0.018), demonstrating a protective
effect of Bmper expression on the degree of plaque growth (Figures 1C, 1D). When lesion
calcification was compared between genotypes, Bmper+/−;ApoE−/− mice again showed an
exacerbated response, with a 120% increase over baseline levels of calcification as
determined by von Kossa staining, compared to a 68% increase in the Bmper+/+;ApoE−/−
mice. This equated to an overall increase in total calcification of 1.12±0.25% in
Bmper+/−;ApoE−/− mice vs. 0.37±0.22% in Bmper+/+;ApoE−/− mice. Bmper+/−;ApoE−/−
mice fed the high fat diet showed no differences in body weight or serum cholesterol levels
compared to Bmper+/+;ApoE−/− mice (Figures S1A, S1B), indicating that diet-induced
increases in weight and lipid levels are not responsible for the more robust atherosclerotic
phenotype in the Bmper+/;ApoE−/− mice. Together, these results indicate that Bmper plays a
protective role in plaque formation and arterial calcification in an in vivo model of
atherosclerosis.
Bmper expression inhibits aortic inflammation
Several reports have demonstrated a central role for the Bmp signaling pathway in
promoting endothelial inflammatory responses8, 9, 18, 19, 22. Therefore, we sought to
determine if the protective influence of Bmper on the development of atherosclerotic lesions
is due to changes in vascular inflammation. To test this, we measured the degree of
macrophage infiltration (a common phenotype observed with the onset of atherosclerotic
plaques1) and expression of inflammatory markers in atherosclerotic plaques in
Bmper+/+;ApoE−/− and Bmper+/−;ApoE−/− mice. Quantitative analysis revealed a more
robust degree of macrophage infiltration (determined by CD68 expression) in aortas of
Bmper+/−;ApoE−/− mice compared to Bmper+/+;ApoE−/− mice (0.143±0.016% CD68
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positive area per aortic cross-sectional area vs. 0.057±0.013%, respectively) following
twenty weeks of the high fat diet (Figures 2A, 2B). Bmper+/−;ApoE−/− mice also exhibited a
dramatic increase in expression of two inflammatory markers, ICAM1 and VCAM1, in the
intima associated with aortic lesions, compared to Bmper+/+;ApoE−/− mice after twenty
weeks of the high fat diet (Figures 2C and 2D), supporting the notion that Bmper functions
as an anti-inflammatory mediator. Similar increases in ICAM1 and VCAM1 expression
were also observed in serum from Bmper+/−;ApoE−/− mice compared to Bmper+/+;ApoE−/−
mice after four weeks of the high fat diet (Figure S2). We also performed immunostaining
with anti-Bmper and Bmp4 antibodies to determine whether there is a change in the level of
expression of these proteins in response vascular inflammation induced by high fat diet. We
observed a robust increase in Bmper (Figure S3A) and Bmp4 (Figure S3B) levels in mice
fed a high fat diet compared to those fed a control diet. This increase in Bmper and Bmp4
correlated with the increased expression of ICAM1/VCAM1 and CD68 signals (Figure 2),
further supporting the notion that the modulation of Bmp signaling by Bmper plays an
important role in the inflammatory responses induced by high fat diet. Collectively, these
data demonstrate that Bmper haploinsufficiency leads to phenotypic changes correlative
with an increased chronic, vascular inflammatory response and likely contributes to the
aggravated atherosclerotic lesion formation observed in the Bmper+/−;ApoE−/− mice.
Bmper inhibits shear stress-dependent induction of inflammatory adhesion molecules in
endothelium
Aortic lesions develop predominantly in regions that are exposed to low or disturbed fluid
shear stress, such as the lesser curvature of the aorta (LC). Even under normal hemodynamic
conditions, previous studies demonstrate higher endothelial inflammation in the LC
compared to other regions of the aorta, such as the greater curvature (GC)3, 4, possibly due
to the increased expression of Bmps in the vascular endothelium of these regions8. This
difference in lesion formation in the GC and LC was also observed in the Bmper
atherosclerosis model. Specifically, we observed that there was a very significant increase in
lesion area in the LC compared to GC of both Bmper+/+;ApoE−/− and Bmper+/−;ApoE−/−
mice (Figure S4). Immunostaining of cross sections of the LC and GC with an antibody
specific for Bmper demonstrated a dramatic increase of Bmper protein levels in intima and
media of the LC compared to the GC in both Bmper+/+ and Bmper+/− mice (Figure S5A). To
quantitatively determine the difference of Bmper protein level in the GC and LC, we also
performed Western blotting with vessel lysates obtained from the GC and LC. We observed
significantly more Bmper protein located in the LC than GC in both Bmper+/+ and Bmper+/−
mice (S5B), suggesting that Bmper protein level is modulated by different fluid shear stress.
Encouraged by these observations, we utilized this inherent difference in vascular
inflammation between the LC and GC to analyze the effect of reduced Bmper expression on
downstream mediators and effectors of BMP activation in these regions of mouse aortas. In
order to simplify our experimental setup we only examined mice on the ApoE+/+
background forwarding subsequent experiments. Endothelial cells located in the LC region
of aortas of Bmper+/+ mice displayed abundant Smad1, 5, 8 activation (as detected by
phosphorylated Smad1, 5, 8 (pSmad) signals) compared to endothelial cells in the GC region
(Figure 3A), consistent with previous reports11. In contrast, Bmper+/− mice exhibited an
enhanced increase in Smad activation in the LC region in compared to Bmper+/+ mice, but
in addition, Bmper+/− mice also had clearly detectable Smad activation in the GC region of
aortas, consistent with our in vivo data described above indicating that Bmper functions as
an anti-inflammatory mediator (Figure 3B). Expression patterns of both ICAM1 and
VCAM1 paralleled that of Smad activation (Figures 3C-3F), demonstrating that Bmper
inhibits the endothelial response to oscillatory shear stress-mediated induction of endothelial
inflammatory adhesion molecules, and in the context of atherosclerosis, may directly inhibit
the endothelial inflammatory response.
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Bmper inhibits Bmp4-induced inflammatory gene expression in endothelial cells and
prevents fluid shear stress-induced inflammatory responses
Our in vivo results clearly support a role for Bmper in suppressing shear stress-mediated
inflammation. To determine the effects of Bmper on inflammation in the endothelial cell
compartment, we established a cell-based model to determine if Bmper's ability to attenuate
inflammation is Bmp4-depedent and in response to fluid shear stress. Treatment of primary
human umbilical vein endothelial cells (HUVECs) with Bmp4 increased ICAM1 and
VCAM1 expression at both the RNA and protein levels in a time-dependent manner, with
peak expression occurring at 8 hours post-treatment (Figures 4A, 4B and data not shown),
consistent with previous reports9, 18. This robust Bmp4-mediated increase in ICAM1 and
VCAM1 expression was blocked in the presence of exogenous Bmper (Figure 4C),
demonstrating that Bmper directly antagonizes Bmp4-mediated inflammatory signaling.
Next we examined the ability of endogenous Bmp4 and Bmper to affect the expression of
inflammatory markers. Given the robust inflammation seen in the normally quiescent GC
region of the aorta in Bmper+/−;ApoE−/− mice, we hypothesized that reducing endogenous
Bmp4 or Bmper expression in endothelial cells would affect the inflammatory signature of
the cells even in the absence of exogenous mediators. As expected, Bmp4-targeted siRNA
reduced expression of ICAM1 and VCAM1 in transfected cells, whereas siRNA-mediated
reduction of endogenous Bmper expression resulted in a significant increase in these same
inflammatory markers (Figures 4D, 4E). Collectively, our data demonstrate that the anti-
inflammatory function of Bmper in endothelial cells is mediated, at least in part, through
antagonizing Bmp activity.
Given the effect of Bmper gene dosage on endothelial inflammation in vivo (Figure 3) and
the in vitro effects of a reduction of Bmper expression on endothelial inflammation in the
absence of any stimuli (Figure 4), we hypothesized that the inflammatory response to shear
stress in the aorta may be mediated by changes in the levels of Bmper expression. To test
this hypothesis directly, we subjected HUVEC to conditions that mimic the shear stress
conditions in the LC and GC aortic regions using either oscillatory stress (±5 dyne cm-2) or
laminar shear stress (20 dyne cm-2) for eight hours, respectively. Consistent with our in vivo
data, endothelial cells subjected to oscillatory shear had a larger inflammatory response (a
2.33-fold and 4.56-fold increase in ICAM1 and VCAM1 expression, respectively) compared
to cells subjected to laminar shear, respectively (Figure 5A). Interestingly, we also observed
increases in Bmp4 and Bmper expression in oscillatory shear conditions compared to
laminar shear conditions (Figure 5A). Moreover, the protein ratio of Bmp4 to Bmper
increased more dramatically in oscillatory shear conditions compared to laminar shear
conditions (Figure 5B). To determine if the inflammatory response observed in our shear
stress model is mediated by changes in Bmper protein level, we used siRNA-mediated gene
silencing of Bmper and compared the extent of inflammatory marker expression to control
siRNA-treated cells. In control siRNA-treated cells, we detected higher ICAM1 and
VCAM1 expression after oscillatory shear compared to laminar shear (Figures 5C-5E), with
similar patterns of Bmp4 and Bmper expression as what was seen in untreated cells exposed
to both modes of shear stress (Figure 5A). In Bmper siRNA-treated cells, we observed an
increased inflammatory response in oscillatory shear conditions compared to control siRNA-
treated cells (Figures 5C-5E), consistent with the increased inflammation we observe in LC
regions in Bmper+/− aortas (Figure 3). Additionally, even in the low inflammatory
environment (laminar shear stress), reducing Bmper expression resulted in 34% and 68%
higher expression of ICAM1 and VCAM1, respectively, compared to control siRNA-treated
cells (Figures 5C-5E), paralleling our observations seen in GC regions of Bmper+/− aortas
(Figure 3). Given that laminar shear stress promotes endothelial survival and integrity by
activating endothelial NOS (eNOS) signaling4, and that Bmper regulates eNOS protein
expression and activity under static conditions19, we tested whether eNOS is regulated by
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Bmper under laminar or oscillatory shear conditions. Very excitingly, we observed that
control siRNA-treated endothelial cells subjected to laminar shear stress for eight hours
displayed a robust increase in eNOS phosphorylation compared to cells subjected to
oscillatory shear stress (Figure 5F, G). However, in Bmper siRNA-treated cells, we
observed a significant decrease in eNOS phosphorylation (Figure 5F, G) after laminar shear
compared to the control-treated cells. This suggests that the protective effect of Bmper under
laminar shear conditions might be mediated by increased eNOS activity. The detailed
mechanism behind this eNOS regulation by Bmper under laminar shear conditions remains
to be determined. Taken together, these data demonstrate a protective role for Bmper in
laminar shear stress environments to reduce endothelial inflammation.
Discussion
In this study, we have identified a previously unrecognized, protective role for Bmper in the
setting of atherosclerosis. ApoE−/− mice, who develop an atherosclerotic phenotype when
fed a high fat diet, displayed significantly worsened symptoms when they carried only one
phenocopy of the Bmper gene (Bmper+/−;ApoE−/− mice). Not only did the decrease in
Bmper levels in these mice cause a dramatic increase in lesion size, it also resulted in
increased arterial calcification and a heightened induction of endothelial inflammatory
adhesion molecules in the aorta in regions subjected to oscillatory and laminar shear stress.
Similar results were found in cultured cell studies, solidifying the notion that Bmper is a
critical regulator of vascular inflammation and broadening our understanding of the role that
Bmper plays in the myriad of events that result from the Bmp signaling pathway.
Previously, our studies revealed the essential roles of Bmp and Bmper signaling in
endothelial cell differentiation, migration and angiogenesis13, 14, 16, 17, 23, 24. With the
results from the present study, we can now add vascular inflammation to the growing list of
Bmp signaling events that are regulated by Bmper. Bmper+/− mice demonstrated increased
Smad activation and expression of the inflammatory markers ICAM1 and VCAM1 in the
endothelium layer of the lesser curvature of the aorta, a region known to be predisposed to
atherogenic activity due to Bmp-mediated vascular inflammation brought about by
oscillatory shear stress effects on endothelial cells (Figure 3). In addition, decreased levels
of Bmper in Bmper+/−;ApoE−/− mice led to an increase in the number of macrophages that
were recruited and that migrated into the inflamed, atherogenic regions of the aortas
(Figures 2A, 2B), supporting the notion that Bmper acts as a protective regulator of vascular
inflammation. It is worth noting however, that Bmper may also play a role in maintaining
general vascular health in addition to its role in inflammatory responses. Our analysis of
aortas taken from ApoE+/+ mice that were haploinsufficient for Bmper (Bmper+/−;ApoE+/+
mice) revealed a significant increase in the area of atherosclerotic lesions in mouse fed a
regular diet (Figures 1A, 1B). This suggests that Bmper may be important in maintaining
vascular health even under basal conditions, a theory that will require further experiments to
determine.
As compelling as these in vivo results are, however, it is important to remember that the
decrease in Bmper expression in the Bmper+/− mouse is not limited to endothelial cells.
Since atherosclerosis is a pathological condition that results from the dysfunction of multiple
cell types and involves different cellular events, it is not possible, from these in vivo studies,
to be able to localize the protective effect of Bmper to endothelial cells alone. Indeed,
published reports demonstrate that Bmps enhance smooth muscle cell migration and induce
proinflammatory factors such as inducible nitric oxide synthase (iNOS) and TNF in
macrophages25, 26. The inhibition of Bmp activity by specific inhibitors and antagonist
decreases vascular calcification, suggesting important roles of Bmp in vascular calcification
as well as early vascular injury10, 11. Therefore, it is entirely possible that Bmper, a secreted
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extracellular Bmp modulator, may also be able to influence Bmp activity not only in
endothelial cells but in additional cell types such as smooth muscle cells and macrophages.
Therefore, the contribution of Bmper to protection against atherogenic processes and
vascular inflammation will need further investigation.
As mentioned above, a number of published reports have detailed the role of Bmper/Bmp
signaling in various aspects of endothelial cell function13, 14, 16, 17, 23, 24. However, the
ability of Bmper to inhibit endothelial inflammatory responses has not been investigated
directly. In order to examine this aspect of endothelial Bmp signaling, we cultured HUVECs
and subjected them to fluid shear stress to induce an inflammatory response similar to what
occurs within atherogenic areas of the aorta. We found that Bmper inhibits the inflammatory
response usually elicited from endothelial cells in response to oscillatory shear stress
(Figures 3 and 5). This result is consistent with other reports demonstrating that the
expression of Bmper and other Bmp antagonists is increased by oscillatory shear stress
compared to laminar shear stress8. Surprisingly, however, we also found that Bmper also
exerts an anti-inflammatory effect on endothelial cells exposed to laminar shear stress.
Laminar shear stress promotes endothelial survival and integrity by activating MAP kinases
such as ERK/BMK1 and endothelial NOS (eNOS) signaling4. Our data have demonstrated
that Bmper is also involved in protecting endothelial cells exposed to laminar shear stress,
partly due to increases in activity of eNOS and decreases ICAM1 and VCAM1 expression
(Figure 5C, F) that have recently been attributed to Bmper activity in endothelial cells19.
The exact molecular mechanisms through which Bmper modulates eNOS activity and other
signaling pathways of laminar shear stress need further investigation.
Bmper has been identified as a critical regulator of Bmp signaling activity, important in both
vascular development and in hypoxia-induced retinal neovascularization13, 14. Previously we
reported a gradient effect of Bmper's ability to influence Bmp signaling, whereby
superstoichiometric concentrations of Bmper compared to Bmp inhibit Bmp signaling and
substoichiometric concentrations of Bmper compared to Bmp activate Bmp signaling13. In
this study, we observed 61% and 15% higher Bmp4 and Bmper expression in oscillatory
shear stress conditions, resulting in a significantly lower Bmper to Bmp4 ratio compared to
laminar shear stress conditions, an expression pattern consistent with an anti-inflammatory
role for Bmper (Figure 5A, B). This observation further suggests that the fine-tuning of Bmp
activity by Bmper is essential for modulating Bmp-mediated cellular functions. Collectively,
the data presented in this report demonstrates that the regulation of Bmp activity by Bmper
is essential for the maintenance of normal vascular homeostasis and its disruption increases
the risk of inflammatory vascular diseases such as atherosclerosis.
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Bmper haploinsufficiency leads to aggravated atherosclerotic plaque formation and lesion
calcification in ApoE−/− mice. Mice were fed a high fat diet (HF) or standard chow (CH) for
twenty weeks. The aorta and heart were dissected out and stained with Oil Red O. A,
Representative images of the Oil Red O staining of aortas. Scale bar, 1.5 mm. B. The lesions
on the surface of each aorta were quantified as a percentage of the total area of the aorta. *,
P<0.05, compared to mice with the same genotype but fed the control diet. #, P<0.05,
compared to mice fed with the same diet but with the ApoE−/− genotype. The numbers
below each column are the number of mice used in the experiments. C, Representative
images of Oil Red O stained sections of aortic sinus regions from mice of the designated
genotype and food groups. Scale bar, 0.2 mm. D, The lesions in the aortic sinus region were
quantified as the percentage of the total lumenal area of aortas. *, P<0.05, compared to mice
with the same genotype but fed the control diet, n≥4. There were no detectable lesions
formed in the aortic sinus regions of ApoE+/+ mice. E, Representative images of
calcification in the aortas and lesions as determined by Von Kossa staining (purple;
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indicated by black arrows). Scale bar, 0.2 mm. F, The area containing calcification
deposition was measured as a percentage of the total lumenal cross-sectional area of aortas.
*, P<0.05, compared to mice fed the same diet but with the ApoE−/− genotype, n≥5. No
detectable calcification detected in aortas of ApoE+/+ mice.
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Bmper haploinsufficiency increases macrophage infiltration and intimal inflammation in
ApoE−/− mice. A, Representative images showing the CD68-labeled macrophages infiltrate
in atherosclerotic lesions of mice of the designated genotype and food group. Scale bars: 100
μm. B, Macrophage infiltration was quantified by measuring the area of CD68-positive cells
and calculating this as a percentage of the total vessel area of aorta studied. *, P<0.05,
compared to mice with the same genotype but fed the control diet. n=3. C-F, ICAM1 (green
in C) and VCAM1 (green in E) immunofluorescence in aortic lesions of mice of the
designated genotype and food group. Shown are representative images of 3-5 mice. Scale
bars: 25 μm. L indicates lumen. M indicates media. Arrows indicate plaques. D, F, The
intimal length containing ICAM1 (Figure C) and VCAM1 (Figure E) was measured as a
percentage of the total intimal conference. *, P<0.05, compared to mice with the same
genotype but fed the control diet, n≥3.
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Bmper haploinsufficiency results in increased Bmp activity and expression of inflammatory
adhesion molecules in the ApoE+/+ endothelium of the greater curvature (GC) and lesser
curvature (LC) of the aortic arch. A, En face staining of the GC and LC in the aortic arch of
Bmper+/− and Bmper+/− mice was performed using an antibody specific for phospho-Smad
1, 5, 8 (pSmad, green). Nuclei were counterstained with DAPI (blue). Arrows indicate
pSmad positive nuclei. Scale bar: 10 μm. B, pSmad-positive nuclei were quantified as a
percentage of all nuclei per field. *, P<0.05, compared to pSmad-positive nuclei (%) in the
GC region of the same mice; #, P<0.05, compared to pSmad-positive nuclei (%) in the same
region of wild-type littermates, n=3. C-F, En face staining was performed for ICAM1 (green
in C) and VCAM1 (green in E) and the endothelial marker CD31 (red in C and E). Scale
bar: 10 μm. D and F, the average intensity of ICAM1 (D) and VCAM1 (F) was measured as
a fold change over the level of intensity in the GC of wild-type mice. *, P<0.05, compared to
the relative expression level in the GC of the same mice; #, P<0.05, compared to the relative
expression level in the same region of wild-type littermates, n=3.
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Bmper inhibits Bmp4-induced ICAM1 and VCAM1 expression. A, HUVECs were treated
with 4 nmol/L of Bmp4 for different time periods as indicated, and then cell lysates were
subjected to Western blotting with specific antibodies against ICAM1 and VCAM1. B,
ICAM1 and VCAM1 band intensity was quantified with ImageJ and normalized against the
actin level. *, P<0.05, compared to the sample without Bmp4 treatment, n=3. C, HUVECs
were treated with 4 nmol/L Bmp4 and increasing concentrations of Bmper (5, 10, 20 nmol/
L) for 8 hours. Cell lysates were then subjected to Western blotting with specific antibodies
against ICAM1 and VCAM1. D, HUVECs were transfected with Bmp4 siRNA or control
siRNA. Eighteen hours later, cells were harvested and subjected to Western blotting. E,
HUVECs were transfected with Bmper siRNAs or control siRNA. Ninety-six hours later,
cells were harvested and subjected to Western blotting.
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Bmper is required for the regulation of ICAM1 and VCAM1 expression by fluid shear
stress. A, HUVECs were subjected to oscillatory shear stress (OS, ±5 dyn cm-2) or laminar
shear stress (LS, 20 dyn cm-2) or remained static in the incubator for 8 hours. Cell lysates
were used for Western blotting to detect the expression of Bmper and Bmp4 and the
induction of inflammatory adhesion molecules ICAM1 and VCAM1. B, The band intensity
of Bmp4 and Bmper (A) was quantified with ImageJ and is presented as the ratio of Bmp4/
Bmper protein level compared to the LS condition. *, P<0.05 compared to the cells exposed
to laminar shear stress. n=4. C, HUVECs were transfected with Bmper or control siRNAs.
Four days later, cells were exposed to oscillatory shear stress (±5 dyn cm-2), laminar shear
stress (20 dyn cm-2) or static conditions for 8 hours. D~E, The band intensity of ICAM1 (D)
and VCAM1 (E) was quantified with ImageJ and is presented as the relative fold change of
protein level compared to the LS condition. *, P<0.05 compared to the cells transfected with
control siRNAs, n=3; #, P<0.05 compared to the cells exposed to laminar shear stress, n=3.
F, HUVECs were transfected with Bmper or control siRNAs. Four days later, cells were
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exposed to oscillatory shear stress (±5 dyn cm-2), laminar shear stress (20 dyn cm-2) or static
conditions for 8 hours. Cell lysates were subjected for Western blotting with phospho-eNOS
(Ser1177) and eNOS antibodies. G, The band intensity of phospho-eNOS (Ser1177)(E) was
quantified with ImageJ and is presented as the relative fold change of protein level
compared to the total eNOS protein level. *, P<0.02 compared to the cells at the static
condition; #, P<0.03 compared to the cells transfected with control siRNA. n=3.
Pi et al. Page 18
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2013 September 01.
$w
aterm
ark-text
$w
aterm
ark-text
$w
aterm
ark-text
